Search by Drug Name or NDC

    NDC 43063-0900-06 LAMIVUDINE and ZIDOVUDINE 150; 300 mg/1; mg/1 Details

    LAMIVUDINE and ZIDOVUDINE 150; 300 mg/1; mg/1

    LAMIVUDINE and ZIDOVUDINE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LAMIVUDINE; ZIDOVUDINE.

    Product Information

    NDC 43063-0900
    Product ID 43063-900_faa8c4b4-55ac-e495-e053-6394a90a8879
    Associated GPIs 12109902500320
    GCN Sequence Number 034186
    GCN Sequence Number Description lamivudine/zidovudine TABLET 150-300 MG ORAL
    HIC3 W5L
    HIC3 Description ANTIVIRALS, HIV-SPEC., NUCLEOSIDE ANALOG, RTI COMB
    GCN 89621
    HICL Sequence Number 014014
    HICL Sequence Number Description LAMIVUDINE/ZIDOVUDINE
    Brand/Generic Generic
    Proprietary Name LAMIVUDINE and ZIDOVUDINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name LAMIVUDINE and ZIDOVUDINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150; 300
    Active Ingredient Units mg/1; mg/1
    Substance Name LAMIVUDINE; ZIDOVUDINE
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleosi
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA079124
    Listing Certified Through 2024-12-31

    Package

    NDC 43063-0900-06 (43063090006)

    NDC Package Code 43063-900-06
    Billing NDC 43063090006
    Package 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-900-06)
    Marketing Start Date 2018-10-11
    NDC Exclude Flag N
    Pricing Information N/A